BENKOWITZ MICHAEL sold UTHR
September 15, 2025 · Form 4 insider transaction
BENKOWITZ MICHAEL sold 2,910 shares of United Therapeutics Corporation at $400.09 per share, a transaction worth $1.16M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3,2025.; This transaction was executed in multiple trades at prices ranging from $399.54 to $400.52. The price reported above reflects the weighted averageprice. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full informationregarding the number of shares and prices at which the transaction was effected.; Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of whichthe Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.